FDA Authorizes Philip Morris to Market 20 Zyn Nicotine Pouches as Less Harmful Than Cigarettes

According to Philip Morris International, the U.S. Food and Drug Administration (FDA) has authorized the company to market 20 Zyn nicotine pouches as less harmful than traditional cigarettes. The authorized products may be promoted as reducing the risk of lung cancer, stroke, and emphysema compared to smoking.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments